Articular cartilage serves as the load-bearing material of joints. One approach to functional tissue engineering is to recapitulate the biochemical and mechanical function of healthy native cartilage in vitro, prior to implantation. We have been successful in cultivating engineered cartilage with compressive mechanical properties and glycosaminoglycan (GAG) content near native values by encapsulating chondrocytes or stem cells in a clinically relevant hydrogel [1, 2]. Clinical application of functional engineered cartilage will likely use of chondrocytes (AC) from osteoarthritic tissue or mesenchymal stem cells (MSCs), which have been shown to have chondrogenic potential. That is, it is may be more feasible to differentiate healthy MSCs towards a chondrogenic lineage than to ‘reprogram’ ACs acquired from an osteoarthritic joint.
- Bioengineering Division
Differences in Engineered Cartilage From Human Chondrocytes and Mesenchymal Stem Cells in Pellet and Construct Culture
- Views Icon Views
- Share Icon Share
- Search Site
O’Connell, GD, Cui, VH, Palmer, G, & Hung, CT. "Differences in Engineered Cartilage From Human Chondrocytes and Mesenchymal Stem Cells in Pellet and Construct Culture." Proceedings of the ASME 2013 Summer Bioengineering Conference. Volume 1A: Abdominal Aortic Aneurysms; Active and Reactive Soft Matter; Atherosclerosis; BioFluid Mechanics; Education; Biotransport Phenomena; Bone, Joint and Spine Mechanics; Brain Injury; Cardiac Mechanics; Cardiovascular Devices, Fluids and Imaging; Cartilage and Disc Mechanics; Cell and Tissue Engineering; Cerebral Aneurysms; Computational Biofluid Dynamics; Device Design, Human Dynamics, and Rehabilitation; Drug Delivery and Disease Treatment; Engineered Cellular Environments. Sunriver, Oregon, USA. June 26–29, 2013. V01AT17A017. ASME. https://doi.org/10.1115/SBC2013-14435
Download citation file: